OpportunityTitle: New Technology to Screen for Mild Hearing Loss in Children (STTR [R41/R42])
AdditionalInformationOnEligibility: Foreign institutions are not eligible to apply. In STTR Phase I and Phase II, at least 40% of the work must be performed by the small business concern and at least 30% of the work must be performed by the single,  partnering  research institution. The basis for determining the percentage of work to be performed by each of the cooperative parties will be the total of direct and F and A/indirect costs attributable to each party, unless otherwise described and justified in Item 12,  Consortium/Contractual Arrangements,  of the PHS398 Research Plan component of the SF424 (R and R) application forms.    The NIH will accept as many &quot;different&quot; applications as the applicant organization chooses. However, the NIH will not accept similar grant applications with essentially the same research focus from the same applicant organization. This includes derivative or multiple applications that propose to develop a single product, process or service that, with non-substantive modifications, can be applied to a variety of purposes. Applicants may not simultaneously submit identical/essentially identical applications under both this funding opportunity and another HHS FOA, including the current SBIR or STTR Parent FOAs.
Description: -This Funding Opportunity Announcement (FOA) solicits Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) for the modification or development of new screening technologies that are better able to consistently detect mild hearing loss (i.e., less than 40 dB Hearing Level or 40 dB HL) in one or both ears in infants and young children without significantly increasing the number of false positives (i.e., those who fail the screen but do not have hearing loss). -The National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH) and the Early Hearing Detection and Intervention (EHDI) program within the National Center for Birth Defects and Developmental Disabilities (NCBDDD), Centers for Disease Control (CDC) is working to ensure infants and children with mild forms of hearing loss are identified as soon as possible. Part of this effort involves having screening technology available that can reliably detect these hearing losses. -This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with an FOA of identical scientific scope, PA-06-546 that solicits applications under the Small Business Innovation Research (SBIR [R43/R44]) grant mechanisms. Note that CDC does not accept STTR applications so is participating only in PA-06-546.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster &lt;br/&gt;FBOWebmaster@OD.NIH.GOV &lt;br/&gt;
CloseDateExplanation: Multiple Receipt Dates - See Link to Full Announcement for details.